{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T15:25:06Z","timestamp":1782141906786,"version":"3.54.5"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012543","name":"Shanghai Science and Technology Development Foundation","doi-asserted-by":"publisher","award":["22QA1407500"],"award-info":[{"award-number":["22QA1407500"]}],"id":[{"id":"10.13039\/100012543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2016YFC0904800"],"award-info":[{"award-number":["2016YFC0904800"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82471104"],"award-info":[{"award-number":["82471104"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ophthalmologyscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Science"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.xops.2026.101107","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T17:18:26Z","timestamp":1770398306000},"page":"101107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Persistent Vision Loss of Eyes Lost to Follow-Up with Diabetic Macular Edema Receiving Intravitreal Anti-VEGF Therapy"],"prefix":"10.1016","volume":"6","author":[{"given":"Chuandi","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinchen","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongqing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yupeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningyao","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbin","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongming","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianzi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuhui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongtong","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongdi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xops.2026.101107_bib1","doi-asserted-by":"crossref","first-page":"P66","DOI":"10.1016\/j.ophtha.2019.09.025","article-title":"Diabetic retinopathy preferred practice pattern(\u00ae)","volume":"127","author":"Flaxel","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101107_bib2","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.13.04126","article-title":"Visual impairment and blindness caused by retinal diseases: a nationwide register-based study","volume":"13","author":"Zhou","year":"2023","journal-title":"J Glob Health"},{"key":"10.1016\/j.xops.2026.101107_bib3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S2213-8587(16)30052-3","article-title":"Diabetic macular oedema","volume":"5","author":"Tan","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.xops.2026.101107_bib4","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ophtha.2018.07.027","article-title":"Outcomes of eyes lost to follow-up with proliferative diabetic retinopathy that received panretinal photocoagulation versus intravitreal anti-vascular endothelial growth factor","volume":"126","author":"Obeid","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101107_bib5","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4610129","article-title":"Treatment efficacy and compliance in patients with diabetic macular edema treated with ranibizumab in a real-life setting","volume":"2018","author":"Best","year":"2018","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101107_bib6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ajo.2020.03.023","article-title":"Predictors of lost to follow-up in patients being treated for proliferative diabetic retinopathy","volume":"216","author":"Green","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101107_bib7","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1007\/s00417-019-04414-y","article-title":"Treatment compliance and adherence among patients with diabetic retinopathy and age-related macular degeneration treated by anti-vascular endothelial growth factor under universal health coverage","volume":"257","author":"Angermann","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.xops.2026.101107_bib8","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/opo.12998","article-title":"An initiative to improve follow-up of patients with diabetic retinopathy","volume":"42","author":"Sabharwal","year":"2022","journal-title":"Ophthalmic Physiol Opt"},{"key":"10.1016\/j.xops.2026.101107_bib9","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.oret.2024.04.016","article-title":"Loss to follow up in patients with proliferative diabetic retinopathy treated with anti-VEGF therapy and\/or panretinal photocoagulation in the United States","volume":"8","author":"Khurana","year":"2024","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.xops.2026.101107_bib10","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2147\/OPTH.S248661","article-title":"Factors affecting compliance to anti-vascular endothelial growth factor treatment of diabetic macular edema in a cohort of Jordanian patients","volume":"14","author":"Abu-Yaghi","year":"2020","journal-title":"Clinical Ophthalmol"},{"key":"10.1016\/j.xops.2026.101107_bib11","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.50942","article-title":"Loss to follow-up in patients with proliferative diabetic retinopathy or diabetic macular edema","volume":"7","author":"Huang","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.xops.2026.101107_bib12","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/02713683.2018.1543708","article-title":"Adherence to intravitreal anti-vascular endothelial growth factor (anti-VEGF) drugs in diabetic macular edema in an Egyptian population: a health belief model","volume":"44","author":"Habib","year":"2019","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.xops.2026.101107_bib13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.oret.2018.11.002","article-title":"Loss to follow-up after intravitreal anti-vascular endothelial growth factor injections in patients with diabetic macular edema","volume":"3","author":"Gao","year":"2019","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.xops.2026.101107_bib14","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.ophtha.2018.02.034","article-title":"Loss to follow-up in patients with proliferative diabetic retinopathy after panretinal photocoagulation or intravitreal anti-VEGF injections","volume":"125","author":"Obeid","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101107_bib15","article-title":"Visual\/anatomical outcome of diabetic macular edema patients lost to follow-up for more than 1 year","volume":"11","author":"Kim","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.xops.2026.101107_bib16","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1097\/IAE.0000000000001892","article-title":"Compliance and adherence of patients with diabetic macular edema to intravitreal anti-vascular endothelial growth factor therapy in daily practice","volume":"38","author":"Weiss","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.xops.2026.101107_bib17","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.4103\/ijo.IJO_1866_19","article-title":"Factors affecting compliance to intravitreal anti-vascular endothelial growth factor therapy in Indian patients with retinal vein occlusion, age-related macular degeneration, and diabetic macular edema","volume":"68","author":"Kelkar","year":"2020","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101107_bib18","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ajo.2020.03.011","article-title":"Loss to follow-up among patients with proliferative diabetic retinopathy in clinical practice","volume":"215","author":"Suresh","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101107_bib19","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3928\/23258160-20180221-06","article-title":"Appointment compliance in patients with diabetic macular edema and exudative macular degeneration","volume":"49","author":"Jansen","year":"2018","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.xops.2026.101107_bib20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ajo.2019.03.005","article-title":"Anti-vascular endothelial growth factor therapy for diabetic retinopathy: consequences of inadvertent treatment interruptions","volume":"204","author":"Wubben","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101107_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2021.06.028","article-title":"Outcomes of eyes with diabetic macular edema that are lost to follow-up after anti-vascular endothelial growth factor therapy","volume":"233","author":"Matsunaga","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101107_bib22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ajo.2020.06.040","article-title":"The short-term effect of a single lapse in anti-vascular endothelial growth factor treatment for diabetic macular edema within routine clinical practice","volume":"219","author":"Yalamanchili","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101107_bib23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1001288","article-title":"Effects of medical therapies on retinopathy progression in type 2 diabetes","volume":"363","author":"Chew","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.xops.2026.101107_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jama.2021.9883","article-title":"Trends in prevalence of diabetes and control of risk factors in diabetes among US adults, 1999-2018","volume":"326","author":"Wang","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.xops.2026.101107_bib25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2147\/OPTH.S151611","article-title":"Association of treatment adherence with real-life VA outcomes in AMD, DME, and BRVO patients","volume":"12","author":"Ehlken","year":"2018","journal-title":"Clinical Ophthalmol"},{"key":"10.1016\/j.xops.2026.101107_bib26","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.ophtha.2015.02.036","article-title":"Predictors of functional and anatomic outcomes in patients with diabetic macular edema treated with ranibizumab","volume":"122","author":"Sophie","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101107_bib27","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/j.ophtha.2007.01.003","article-title":"Relationship of macular microcirculation and retinal thickness with visual acuity in diabetic macular edema","volume":"114","author":"Sakata","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101107_bib28","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.ophtha.2024.01.037","article-title":"Risk factors for meeting criteria for switching from bevacizumab to aflibercept when treating eyes with diabetic macular edema and visual acuity of < 20\/40","volume":"131","author":"Jhaveri","year":"2024","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101107_bib29","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJMoa2204225","article-title":"Aflibercept monotherapy or bevacizumab first for diabetic macular edema","volume":"387","author":"Jhaveri","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.xops.2026.101107_bib30","first-page":"91","article-title":"Keypoints in Evidence-based guidelines for diagnosis and treatment of diabetic retinopathy in China (2022)","volume":"39","author":"Li","year":"2023","journal-title":"Chin J Ocul Fundus Dis"}],"container-title":["Ophthalmology Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266691452600045X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266691452600045X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T12:25:11Z","timestamp":1777638311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266691452600045X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S266691452600045X"],"URL":"https:\/\/doi.org\/10.1016\/j.xops.2026.101107","relation":{},"ISSN":["2666-9145"],"issn-type":[{"value":"2666-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Persistent Vision Loss of Eyes Lost to Follow-Up with Diabetic Macular Edema Receiving Intravitreal Anti-VEGF Therapy","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xops.2026.101107","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Ophthalmology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101107"}}